Secondary Logo

Journal Logo

Articles by Samuel Ferret, MD

Bone Mineral Density Over 96 Weeks in Adults Failing First-Line Therapy Randomized to Raltegravir/Lopinavir/Ritonavir Compared With Standard Second-Line Therapy

Haskelberg, Hila; Mallon, Patrick W.G.; Hoy, Jennifer; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(2):161-168, October 1st, 2014.